Keith Woods
CIK 1996804 · Chief Operating Officer · last filed 2026-09-25
Keith Woods is a Chief Operating Officer who has filed 19 SEC Form 4 insider transactions across 5 companies since 2023. The most recent filing, for SRRK, was dated Sep 25, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $25.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SRRK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
61 NORTH BEACON STREET 4TH FLOOR
BOSTON, MA 02134
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | Chief Operating Officer | 620,055 | $41.71 | $25.86M | -$1.22M | 6 | 2026-09-25 |
| NGNE | Director | — | $23.54 | — | $0 | 4 | 2026-06-16 |
| TCRX | Director | — | $0.19 | — | $0 | 4 | 2026-05-22 |
| XFOR | Director | 6,000 | $3.25 | $19.5K | $0 | 3 | 2025-06-10 |
| ROCKET PHARMACEUTICALS, INC. (RCKTW) Delisted | Director | — | $0.00 | — | $0 | 2 | 2024-06-20 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-25 | SRRK | Gift (G) | −48,034 | $0 | EDGAR |
| 2026-06-16 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2026-06-16 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2026-06-16 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2026-05-22 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2026-04-20 | SRRK | Sell (S) | −10,220 | -$506.7K | EDGAR |
| 2026-02-24 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2026-02-11 | SRRK | Grant (A) | +47,021 | $0 | EDGAR |
| 2026-01-15 | SRRK | Sell (S) | −16,746 | -$715.1K | EDGAR |
| 2025-07-02 | TCRX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.